Researchers Call for a Halt of $63M Cardiac Stem Cell Trial

October 22, 2018

(Cardiovascular Business) – Cardiologists and researchers alike are calling for the early halt of a national heart stem cell trial after Harvard Medical School and Brigham and Women’s Hospital expressed concern earlier this week that some of the work the study is based on might be falsified.